Overview
Michael Winther practices practicing medicine in Singapore, Singapore.
His clinical expertise encompasses Defective Apolipoprotein B-100 and Familial Hypercholesterolemia.
He is actively involved in clinical research, co-authoring 16 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Michael D. Winther
Is Michael D. Winther a top-rated expert for Defective Apolipoprotein B-100?
MediFind is an objective health platform that identifies experts based on real-world data. Michael D. Winther is classified as an Experienced expert for Defective Apolipoprotein B-100, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Michael D. Winther participate in research or clinical trials?
Yes. Michael D. Winther has published 16 articles and abstracts on conditions like Defective Apolipoprotein B-100. You can view a list of Michael D. Winther's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Defective Apolipoprotein B-100Mr. Winther isExperienced. Learn about Defective Apolipoprotein B-100.
- Familial HypercholesterolemiaMr. Winther isExperienced. Learn about Familial Hypercholesterolemia.